[ad_1]
Crown vaccine maker AstraZeneca threatens more delivery bottlenecks. Company representatives also reportedly informed the European Union about possible production stops in Europe during the second quarter, said a representative of the German Press Agency in the EU in Brussels. But, in theory, these amounts could be offset by the manufacturer’s other vaccine factories.
The EU representative reacted to media reports that AstraZeneca wanted to cut second-quarter delivery in half from 180 million to 90 million cans. This could not be confirmed, dpa was now told. The commission officially announced that negotiations with AstraZeneca on the delivery schedule were still ongoing. The company is in the process of “refining and consolidating the plan, based on all available production facilities in Europe and abroad.” The commission expects “an improved proposal for a delivery schedule.”
At the end of January, AstraZeneca had surprisingly announced a drastic reduction in delivery volumes to the EU: instead of 80 million cans, the British-Swedish company wanted to deliver only 31 million to the EU due to production bottlenecks. in Europe. Finally, the company promised 40 million cans for the period through March. However, it is unclear whether this amount will actually be achieved, he said from EU circles.
A spokeswoman for AstraZeneca said delivery schedules are constantly being reviewed and the commission will be reported weekly. We are working to increase the productivity of the supply chain in the EU and we do our best to use the global supply chain. The company later told the Dutch TV broadcaster NOS that half of the promised delivery volume would come from production lines in the EU, the rest should be produced elsewhere.
